1 - 25 of 2
Number of results to display per page
TitleDateType
1 Safety/Acuity Outcomes 96-Weeks Post-Treatment with rAAV2/2-ND4; Gene Therapy for ND4 LHON: a Phase I/II Trial2018-04Image/MovingImage
2 Safety/Acuity Outcomes 96-Weeks Post-Treatment with rAAV2/2-ND4; Gene Therapy for ND4 LHON: a Phase I/II Trial2018-04Text
1 - 25 of 2